Abortifacient Agents, Steroidal
"Abortifacient Agents, Steroidal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Steroidal compounds with abortifacient activity.
| Descriptor ID |
D000021
|
| MeSH Number(s) |
D27.505.696.875.131.200 D27.505.954.705.131.200
|
| Concept/Terms |
Abortifacient Agents, Steroidal- Abortifacient Agents, Steroidal
- Agents, Steroidal Abortifacient
- Steroidal Abortifacient Agents
- Steroid Abortifacients
- Abortifacients, Steroid
|
Below are MeSH descriptors whose meaning is more general than "Abortifacient Agents, Steroidal".
Below are MeSH descriptors whose meaning is more specific than "Abortifacient Agents, Steroidal".
This graph shows the total number of publications written about "Abortifacient Agents, Steroidal" by people in this website by year, and whether "Abortifacient Agents, Steroidal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Abortifacient Agents, Steroidal" by people in Profiles.
-
Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation. Implement Sci. 2021 08 03; 16(1):76.
-
An introduction to risk evaluation and mitigation strategies. Contraception. 2021 07; 104(1):4-7.
-
The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States. Contraception. 2021 07; 104(1):38-42.
-
Abortion exceptionalism and the mifepristone REMS. Contraception. 2021 07; 104(1):8-11.
-
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. Contraception. 2021 07; 104(1):43-48.
-
Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019. Issues Law Med. 2021; 36(1):3-26.
-
American College of Obstetricians and Gynecologists v. United States Food & Drug Administration: Restricted Access to Medical Abortion Threatens Reproductive Rights during the COVID-19 Pandemic. Am J Law Med. 2020 11; 46(4):507-517.
-
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond. Contraception. 2020 06; 101(6):361-366.
-
Management of first-trimester miscarriage: a systematic review and network meta-analysis. Hum Reprod Update. 2019 05 01; 25(3):362-374.